Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Albert Einstein College of Medicine
Radioactive glucose goes from diagnostic tool to cancer therapy
September 10th, 2003
Cancer patients could be benefiting more than they realize from diagnostic scans. Research published in the August 21, 2003, issue of Breast Cancer Research suggests that a radioactive molecule widely used to evaluate advanced tumors can kill cancer cells. Dr. Ekaterina Dadachova and her team from the Albert Einstein College of Medicine of Yeshiva University, New York, examined how radioactive glucose affects breast tumors in mice. They found that, injected at certain doses, the radiation from the glucose killed cancer cells without being toxic to other tissues. Glucose tagged with radioactive fluorine-18 is commonly used...
Source: Biotech Week (2003-09-10)
|
